Tweet
Wall Street Journal |
Alzheimer's therapy flops in phase III clinical trial Science AAAS Swiss pharmaceutical giant Roche announced today it is ending a phase III clinical trial for the experimental drug gantenerumab, a monoclonal antibody therapy, because the drug has failed to actually help prevent Alzheimer's disease, Bloomberg reports. Double blow for Roche as breast cancer, Alzheimer's studies failReuters all 89 news articles » |
More...